METHODS : Stage IIIb or IV NSCLC patients , with two or fewer prior chemotherapy regimens , one platinum based ( stratum 1 ) or both chemotherapy and epidermal growth factor receptor tyrosine kinase inhibitors ( stratum 2 ) , received RAD001 10 mg/day until progression or unacceptable toxicity .
O O O O O O B-DiseaseOrPhenotypicFeature B-OrganismTaxon O O O O O O O O O O B-ChemicalEntity O O O O O O O O O B-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct O O O O O O O B-ChemicalEntity O O O O O O B-DiseaseOrPhenotypicFeature O